The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.
about
Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposalDexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortexHaemolytic uraemic syndrome.Epidemiological characteristics of reported sporadic and outbreak cases of E. coli O157 in people from Alberta, Canada (2000-2002): methodological challenges of comparing clustered to unclustered data.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.Childhood hemolytic uremic syndrome, United Kingdom and Ireland.Hemolytic uremic syndrome risk and Escherichia coli O157:H7.Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.A novel antimicrobial peptide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes.Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyShigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Thrombotic microangiopathy: E. coli O104:H4 German outbreak: a missed opportunity.[Management of patients with EHEC/HUS. Lessons and perspectives from clinical infectious disease specialists].Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection.Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy.A large Great Britain-wide outbreak of STEC O157 phage type 8 linked to handling of raw leeks and potatoes.Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.Genome-wide transposon mutagenesis reveals a role for pO157 genes in biofilm development in Escherichia coli O157:H7 EDL933Neuropsychological outcome after complicated Shiga toxin-producing Escherichia coli infectionTherapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak.Genomic characterisation of an endometrial pathogenic Escherichia coli strain reveals the acquisition of genetic elements associated with extra-intestinal pathogenicity.Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.Three years experience of adults admitted to hospital in north-east Scotland with E. coli O157.Molecular basis of virulence in clinical isolates of Escherichia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South Africa.Rifaximin for the treatment of acute infectious diarrheaUnderlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases.The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions.Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study.Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific KetolidesEffects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coliLessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coliShiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
P2860
Q26827657-E4D8B0AD-F54E-4E86-A49F-CF4C79AC8732Q28534818-BB897034-953F-4CB9-896D-FD4EBB997F21Q30244707-A314CD1F-E19E-4616-A404-E1A57629122CQ33287522-4E5B80FA-FC69-48C1-9B01-E7739F6AD2BFQ33346559-C03E00EE-3A7E-4476-8AC1-F508656BAF84Q33365828-CBE54952-C644-4241-8494-15D00140222BQ33370290-5721F3A7-F673-4326-B235-184A4BD8A647Q33372310-3C4411BC-A4DE-45A3-97C0-66FCBBBAEA29Q33373301-D67D42B8-854E-4264-82B1-062DC09BD7EAQ33376327-F3488C4F-41D9-46E0-88C1-F8EDC65F61C1Q33379319-63306716-8F36-4DCD-AAA6-CA68B968476AQ33394720-980059D9-456F-40BE-95FF-01B0819BAAEAQ33400310-56C915A2-F314-416D-A2C2-7AECD753E9D9Q33400961-6F2E72CE-B99C-4F36-B8EC-41BED217A2BEQ33402456-B36B08E1-5C8A-44B2-B8E6-7ACB2952C7ECQ33402784-532062EC-2BCD-44DF-887A-0E55A1929075Q33403105-FBF031F0-DDCE-499E-9415-EE28EA76ABF9Q33405034-7FAEE0EA-0BE9-4657-A308-2A0FB3AB047FQ33406669-264D2F48-ADA2-4E67-B097-E6CDB0E6923BQ33412570-991CA1CB-6BF4-4B20-8E97-79CFCF4B6E5BQ33419863-D172C607-F765-4A50-BAEC-83DF03326A47Q33423362-E9B8428B-B607-4051-B771-194F1AF26FE1Q33426758-1D9264F4-210C-46F7-A3F8-ABDDB516A61CQ33429632-076E3E5F-E978-4F5E-9713-44E80F61DFC9Q33547277-37367348-3955-49AC-8390-AFD9E6B99F3DQ33933481-F3517C5C-A647-429A-A87C-98A31298F7E9Q34361876-E793DEA3-79F7-41C2-B83E-33B9E2FAD0E2Q34984523-1A1FA516-BBE1-459A-8975-63800B0D8541Q34989499-4E13D28A-4D29-4B4D-9936-4BDF023E8279Q35018603-CF12193D-750E-45AB-8B9A-5865D700998EQ35074276-CE87C0F4-1C34-4ABD-92CF-35A5AA7F61F8Q35090413-02917720-FC80-4302-9831-7E2D1900BF75Q35128249-343D8D47-ABF3-4DCA-9727-F288046F52EDQ35180934-A05A91B3-BB7C-4563-AB88-F6FB50B1FBBDQ35324691-2BFACBE7-35B2-4434-A1F8-B5152997D885Q35829561-60DE70AD-B208-4AB3-A97D-A10526D5949CQ36018770-2363D80F-0374-4C72-9487-A6C6BC5DF24DQ36405482-E4F50F18-7373-459D-ABD6-CB62C482A4A1Q36563022-133BD84D-08B8-43B9-90C1-BDA4B5656EB6Q36837884-0196627E-19DD-42E0-A1DD-5FEA72EC5D95
P2860
The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The central Scotland Escherich ...... h among hospitalized patients.
@ast
The central Scotland Escherich ...... h among hospitalized patients.
@en
The central Scotland Escherich ...... h among hospitalized patients.
@nl
type
label
The central Scotland Escherich ...... h among hospitalized patients.
@ast
The central Scotland Escherich ...... h among hospitalized patients.
@en
The central Scotland Escherich ...... h among hospitalized patients.
@nl
prefLabel
The central Scotland Escherich ...... h among hospitalized patients.
@ast
The central Scotland Escherich ...... h among hospitalized patients.
@en
The central Scotland Escherich ...... h among hospitalized patients.
@nl
P2093
P2860
P921
P356
P1476
The central Scotland Escherich ...... h among hospitalized patients.
@en
P2093
Chaudhuri AK
Hutchinson SJ
Murdoch PS
Stewart AI
P2860
P304
P356
10.1086/322598
P407
P577
2001-09-05T00:00:00Z